标题
A novel rapamycin analog is highly selective for mTORC1 in vivo
作者
关键词
-
出版物
Nature Communications
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-19
DOI
10.1038/s41467-019-11174-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Next generation strategies for geroprotection via mTORC1 inhibition
- (2019) Sabrina N Dumas et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects
- (2018) Ellen Kraig et al. EXPERIMENTAL GERONTOLOGY
- TORC1 inhibition enhances immune function and reduces infections in the elderly
- (2018) Joan B. Mannick et al. Science Translational Medicine
- Mammalian target of rapamycin complex 2 regulates muscle glucose uptake during exercise in mice
- (2017) Maximilian Kleinert et al. JOURNAL OF PHYSIOLOGY-LONDON
- Restoration of metabolic health by decreased consumption of branched-chain amino acids
- (2017) Nicole E. Cummings et al. JOURNAL OF PHYSIOLOGY-LONDON
- RHEB1 insufficiency in aged male mice is associated with stress-induced seizures
- (2017) Qi Tian et al. GeroScience
- A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs
- (2017) Silvan R. Urfer et al. GeroScience
- Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study
- (2017) John J. Bissler et al. PLoS One
- Rheb1 deletion in myeloid cells aggravates OVA-induced allergic inflammation in mice
- (2017) Kai Li et al. Scientific Reports
- Everolimus pharmacokinetics and its exposure–toxicity relationship in patients with thyroid cancer
- (2016) D. de Wit et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging
- (2016) Brian K. Kennedy et al. Cell Metabolism
- Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice
- (2016) Sebastian I. Arriola Apelo et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
- (2016) James C Yao et al. LANCET
- Long-term treatment of epilepsy with everolimus in tuberous sclerosis
- (2016) Darcy A. Krueger et al. NEUROLOGY
- Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism
- (2016) Yuefeng Tang et al. Nature Communications
- Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice
- (2016) Alessandro Bitto et al. eLife
- Rapamycin-induced metabolic defects are reversible in both lean and obese mice
- (2016) Yuhong Liu et al. Aging-US
- Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins
- (2015) Katherine H. Schreiber et al. AGING CELL
- Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system
- (2015) Sebastian I. Arriola Apelo et al. AGING CELL
- Complications of mammalian target of rapamycin inhibitor anticancer treatment among patients with tuberous sclerosis complex are common and occasionally life-threatening
- (2015) Joanna Trelinska et al. ANTI-CANCER DRUGS
- mTOR inhibitors and diabetes
- (2015) Bruno Vergès et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2
- (2015) David J Kwiatkowski et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
- (2015) Sara A Hurvitz et al. LANCET ONCOLOGY
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart
- (2014) Dao-Fu Dai et al. AGING CELL
- Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms
- (2014) Emily L. Goldberg et al. AGING CELL
- Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan
- (2014) Dudley W. Lamming et al. AGING CELL
- Genetic Deletion of Rheb1 in the Brain Reduces Food Intake and Causes Hypoglycemia with Altered Peripheral Metabolism
- (2014) Wanchun Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune Memory–Boosting Dose of Rapamycin Impairs Macrophage Vesicle Acidification and Curtails Glycolysis in Effector CD8 Cells, Impairing Defense against Acute Infections
- (2014) Emily L. Goldberg et al. JOURNAL OF IMMUNOLOGY
- Renal tumours in a Tsc2+/− mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin
- (2014) J Yang et al. ONCOGENE
- Beneficial Metabolic Effects of Rapamycin Are Associated with Enhanced Regulatory Cells in Diet-Induced Obese Mice
- (2014) Kassem Makki et al. PLoS One
- mTOR inhibition improves immune function in the elderly
- (2014) J. B. Mannick et al. Science Translational Medicine
- Strategies for the management of adverse events associated with mTOR inhibitors
- (2014) Bruce Kaplan et al. Transplantation Reviews
- Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive
- (2013) Dudley W. Lamming et al. AGING CELL
- Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
- (2013) Richard A. Miller et al. AGING CELL
- A Central Role for mTOR in Lipid Homeostasis
- (2013) Dudley W. Lamming et al. Cell Metabolism
- A role for Raptor phosphorylation in the mechanical activation of mTOR signaling
- (2013) John W. Frey et al. CELLULAR SIGNALLING
- Rapalogs and mTOR inhibitors as anti-aging therapeutics
- (2013) Dudley W. Lamming et al. JOURNAL OF CLINICAL INVESTIGATION
- Insulin Inhibits Lipolysis in Adipocytes via the Evolutionarily Conserved mTORC1-Egr1-ATGL-Mediated Pathway
- (2013) P. Chakrabarti et al. MOLECULAR AND CELLULAR BIOLOGY
- Large FK506-Binding Proteins Shape the Pharmacology of Rapamycin
- (2013) A. M. Marz et al. MOLECULAR AND CELLULAR BIOLOGY
- Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma
- (2013) D. A. Krueger et al. NEUROLOGY
- Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
- (2013) Sefika Ozcelik et al. PLoS One
- Rapamycin slows aging in mice
- (2012) John E. Wilkinson et al. AGING CELL
- Regulation of Immune Responses by mTOR
- (2012) Jonathan D. Powell et al. Annual Review of Immunology
- TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO
- (2012) Stacey Robida-Stubbs et al. Cell Metabolism
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
- (2012) Lan Ye et al. Frontiers in Genetics
- Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling
- (2011) Smita Majumder et al. AGING CELL
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
- (2011) Timothy R. Peterson et al. CELL
- Regulatory T Cells Require Mammalian Target of Rapamycin Signaling To Maintain Both Homeostasis and Alloantigen-Driven Proliferation in Lymphocyte-Replete Mice
- (2011) Y. Wang et al. JOURNAL OF IMMUNOLOGY
- The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling
- (2011) P. P. Hsu et al. SCIENCE
- Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster
- (2010) Ivana Bjedov et al. Cell Metabolism
- Fat Cell-Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism
- (2010) A. Kumar et al. DIABETES
- mTORC1 Inhibition via Rapamycin Promotes Triacylglycerol Lipolysis and Release of Free Fatty Acids in 3T3-L1 Adipocytes
- (2010) Ghada A. Soliman et al. LIPIDS
- Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
- (2010) Katrin Düvel et al. MOLECULAR CELL
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
- (2010) Patricia Spilman et al. PLoS One
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
- (2009) Carson C. Thoreen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
- (2009) David E. Harrison et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation